BibTex RIS Kaynak Göster

Yıl 2013, Cilt: 3 Sayı: 1, 37 - 39, 01.01.2013

Başar Altınterim

Öz

Kaynakça

  • Aberg, B. 1981. Plant growth regulators. XLI. Monosubstituted benzoic acids. Swedish J. Agric. Res. 11: 93–105.
  • Bergner, P. 2001. Salix: Willow bark and NSAID. Medical Herbalism. Mat. Med. and Phar. 3: 2–7.
  • Blumenthal, M., Busse WR., Goldberg A., Gruenwald, J., Hall, T., Riggins, CW., Rister, RS., eds. Klein S., Rister, RS. 1998. The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines. Austin, TX: Am. Bot. Coun.. Boston: Integrative Medicine Communication.
  • Bradley, PR. 1992. British Herbal Compendium, vol 1. Bournemouth, Dorset, UK. British Herbal Med. Ass. 224–6.
  • Chrubasik, S., Shvartzman, P. 1999. Rheumatic Pain Treatment With Willow Bark (Salicis Cortex). Coherence, 1. 1/99.
  • Fiebich, BL, Appel K. 2003. Anti-inflammatory effects of willow bark extract. Clin. Phar. Ther. 74: 96.
  • Food and Drug Administration, 2003. HHS: Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye’s syndrome warning. Final rule. Fed. Regist. 68: 18861-9.
  • Hathcock, J. 1997. Vitamin and Mineral Safety. Council for Responsible Nutrition:Washington DC. 30-32, 39, 41-46, 49-50.
  • MacLagan, TJ. 1876. The treatment of acute rheumatism by salicin. Lancet. 342-383.
  • Newall, CA., Anderson, LA., Philpson, JD. 1996. Herbal Medicine. A Guide for Healthcare Professionals. London, UK. The Pharmaceutical Press. 296.
  • Quick, AJ. 1966. Salicylates and bleeding: the aspirin tolerance test. Am. J. Med. Sci. 252:265–9.
  • Peirce, A. 1999. The American Pharmaceutical Association practical guide to natural medicines. New York. William Morrow and Company, Inc.
  • Ruggeri, ZM. 2002. Platelets in atherothrombosis. Nat. Med. 8: 1227–34.
  • Schrör, K. 2009. Acetylsalicylic Acid. Weinheim. ISBN: 978–3– 527–32109–4 Copyright. WILEY-VCH Verlag GmbH & Co. KGaA. 29 p.
  • Szczeklik, A., Nizankowski, R., Skawinski, S., Szczeklik, J., Gluszko, P., Gryglewski, RJ. 1979. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet, 1:1111-1114.
  • Vlachojannis, J., Magora, F., Chrubasik, S. 2011. Willow Species and Aspirin: Different Mechanism of Actions. Phytotherapy Res., 25: 1102–1104.
  • Weiss, HJ, Aledort, LM. 1967. Impaired platelet-connective- tissue reaction in man after aspirin ingestion. Lancet, 2: 495–7.

EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT

Yıl 2013, Cilt: 3 Sayı: 1, 37 - 39, 01.01.2013

Başar Altınterim

Öz

The herb white willow Salix alba , also known as willow bark, is used to treat pain and fever. White willow contains a substance salicine that is converted by the body into a salicylate similar to the blood-thinner aspirin. Over the last twenty years, yet another use for aspirin has emerged connected with the discovery of its anti-thrombotic action.

Anahtar Kelimeler

Willow bark Blood Coagulant saline.

Kaynakça

  • Aberg, B. 1981. Plant growth regulators. XLI. Monosubstituted benzoic acids. Swedish J. Agric. Res. 11: 93–105.
  • Bergner, P. 2001. Salix: Willow bark and NSAID. Medical Herbalism. Mat. Med. and Phar. 3: 2–7.
  • Blumenthal, M., Busse WR., Goldberg A., Gruenwald, J., Hall, T., Riggins, CW., Rister, RS., eds. Klein S., Rister, RS. 1998. The Complete German Commission E Monographs Therapeutic Guide to Herbal Medicines. Austin, TX: Am. Bot. Coun.. Boston: Integrative Medicine Communication.
  • Bradley, PR. 1992. British Herbal Compendium, vol 1. Bournemouth, Dorset, UK. British Herbal Med. Ass. 224–6.
  • Chrubasik, S., Shvartzman, P. 1999. Rheumatic Pain Treatment With Willow Bark (Salicis Cortex). Coherence, 1. 1/99.
  • Fiebich, BL, Appel K. 2003. Anti-inflammatory effects of willow bark extract. Clin. Phar. Ther. 74: 96.
  • Food and Drug Administration, 2003. HHS: Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye’s syndrome warning. Final rule. Fed. Regist. 68: 18861-9.
  • Hathcock, J. 1997. Vitamin and Mineral Safety. Council for Responsible Nutrition:Washington DC. 30-32, 39, 41-46, 49-50.
  • MacLagan, TJ. 1876. The treatment of acute rheumatism by salicin. Lancet. 342-383.
  • Newall, CA., Anderson, LA., Philpson, JD. 1996. Herbal Medicine. A Guide for Healthcare Professionals. London, UK. The Pharmaceutical Press. 296.
  • Quick, AJ. 1966. Salicylates and bleeding: the aspirin tolerance test. Am. J. Med. Sci. 252:265–9.
  • Peirce, A. 1999. The American Pharmaceutical Association practical guide to natural medicines. New York. William Morrow and Company, Inc.
  • Ruggeri, ZM. 2002. Platelets in atherothrombosis. Nat. Med. 8: 1227–34.
  • Schrör, K. 2009. Acetylsalicylic Acid. Weinheim. ISBN: 978–3– 527–32109–4 Copyright. WILEY-VCH Verlag GmbH & Co. KGaA. 29 p.
  • Szczeklik, A., Nizankowski, R., Skawinski, S., Szczeklik, J., Gluszko, P., Gryglewski, RJ. 1979. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet, 1:1111-1114.
  • Vlachojannis, J., Magora, F., Chrubasik, S. 2011. Willow Species and Aspirin: Different Mechanism of Actions. Phytotherapy Res., 25: 1102–1104.
  • Weiss, HJ, Aledort, LM. 1967. Impaired platelet-connective- tissue reaction in man after aspirin ingestion. Lancet, 2: 495–7.
Toplam 17 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Research Article
Yazarlar

Başar Altınterim Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2013
Yayımlandığı Sayı Yıl 2013 Cilt: 3 Sayı: 1

Kaynak Göster

APA Altınterim, B. (2013). EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT. Karaelmas Fen Ve Mühendislik Dergisi, 3(1), 37-39.
AMA Altınterim B. EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT. Karaelmas Fen ve Mühendislik Dergisi. Ocak 2013;3(1):37-39.
Chicago Altınterim, Başar. “EFFECTS OF WILLOW BARK Salix Alba AND ITS SALICYLATES ON BLOOD COAGULANT”. Karaelmas Fen Ve Mühendislik Dergisi 3, sy. 1 (Ocak 2013): 37-39.
EndNote Altınterim B (01 Ocak 2013) EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT. Karaelmas Fen ve Mühendislik Dergisi 3 1 37–39.
IEEE B. Altınterim, “EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT”, Karaelmas Fen ve Mühendislik Dergisi, c. 3, sy. 1, ss. 37–39, 2013.
ISNAD Altınterim, Başar. “EFFECTS OF WILLOW BARK Salix Alba AND ITS SALICYLATES ON BLOOD COAGULANT”. Karaelmas Fen ve Mühendislik Dergisi 3/1 (Ocak 2013), 37-39.
JAMA Altınterim B. EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT. Karaelmas Fen ve Mühendislik Dergisi. 2013;3:37–39.
MLA Altınterim, Başar. “EFFECTS OF WILLOW BARK Salix Alba AND ITS SALICYLATES ON BLOOD COAGULANT”. Karaelmas Fen Ve Mühendislik Dergisi, c. 3, sy. 1, 2013, ss. 37-39.
Vancouver Altınterim B. EFFECTS OF WILLOW BARK Salix alba AND ITS SALICYLATES ON BLOOD COAGULANT. Karaelmas Fen ve Mühendislik Dergisi. 2013;3(1):37-9.